跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RISPERIDONE SANDOZ risperidone 4mg film-coated tablet in blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RISPERIDONE SANDOZ risperidone 4mg film-coated tablet in blister pack
Approved
STANDARD
RISPERIDONE SANDOZ risperidone 4mg film-coated tablet in blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
35f75be8a0f5bcee
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
35f75be8a0f5bcee
Product Name
RISPERIDONE SANDOZ risperidone 4mg film-coated tablet in blister pack
Artg Id
126160
Artg Name
RISPERIDONE SANDOZ risperidone 4mg film-coated tablet in blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2007-09-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f8f3147e9ab43755bbfc6ce8646f94e8.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4e2bc418444e6d41e6a9abcf9832e95c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
35f75be8a0f5bcee
Type
Standard
Back to TGA Approvals